Oramed Pharmaceuticals
ORMP
#9008
Rank
NZ$0.24 B
Marketcap
NZ$5.98
Share price
0.88%
Change (1 day)
57.33%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): NZ$98.84 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are NZ$2 Million. In 2024 the company made an earning of -NZ$26.36 Million a decrease over its 2023 earnings that were of NZ$12.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$98.84 M-475.1%
2024 -NZ$26.36 Million-311.47%
2023 NZ$12.46 M-119.45%
2022 -NZ$64.07 Million39.17%
2021 -NZ$46.04 Million73.93%
2020 -NZ$26.47 Million18.53%
2019 -NZ$22.33 Million-16.62%
2018 -NZ$26.78 Million38.32%
2017 -NZ$19.36 Million12.51%
2016 -NZ$17.21 Million25.01%
2015 -NZ$13.77 Million18.18%
2014 -NZ$11.65 Million39.72%
2013 -NZ$8.34 Million46.4%
2012 -NZ$5.7 Million128.32%
2011 -NZ$2.5 Million-51.47%
2010 -NZ$5.14 Million35.21%
2009 -NZ$3.81 Million
2007 -NZ$5.98 Million607.04%
2006 -NZ$0.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$36.66 B 35,853.48%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$13.46 B 13,105.89%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion-973.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-NZ$48.21 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel